LEO Pharma Launches First North American Innovation Lab in Toronto

Leo Pharma.jpg

LEO Pharma, Denmark's oldest healthcare company, announced today the launch of its innovation lab in Toronto, first in North America. Backed by $100M CDN in funding, LEO Innovation Lab will develop new, non-pharmaceutical solutions for people living with psoriasis and partner with the startup community to foster innovation in apps, web platforms, wearables, virtual reality, artificial intelligence, tele-medicine and other advanced technologies. Located north of Toronto in Markham, LEO Innovation Lab is LEO Pharma's first innovation venture outside of Europe. Similar innovation labs today operate in Copenhagen, London and Paris.

Click here for full article.